Biased Ligands. Better Drugs.

TRV734 Phase 1 formulation study

Formulation and Food Effect Studies of TRV734, an Oral, G Protein-biased Ligand of the ยต-opioid Receptor

Franck Skobieranda, MD, Ian E. James, PhD, Michael J. Fossler, PharmD, PhD, Gregory Alcorn, PhD, David G. Soergel, MD.

View PDF

Copyright © Trevena, Inc.